Annual Savings from FDA Generic Approvals: Year-by-Year Breakdown
Explore the year-by-year breakdown of annual savings from FDA generic drug approvals. Discover how new entries cut costs by 70%, totaling billions in economic relief.
Read More
Explore the year-by-year breakdown of annual savings from FDA generic drug approvals. Discover how new entries cut costs by 70%, totaling billions in economic relief.
Read More
Discover the fascinating history of generic drugs in the US, from early standardization and the Hatch-Waxman Act to the modern era of biosimilars.
Read More
The Hatch-Waxman Act revolutionized U.S. drug access by creating a legal pathway for generic drugs to enter the market without repeating clinical trials. It saved trillions and now governs how 90% of prescriptions are filled.
Read More